Psoriasis-associated molecular pathways, the IL-23/Th17 axis and the JAK-STAT pathway, have been explored, and structural optimization of small-molecule inhibitors has been obtained through molecular docking and kinetic simulations. Here, SOAT1 is linked to psoriasis.